The cytotoxic effects of diketopiperaizes against Leishmania donovani promastigotes and amastigotes

Medicinal Chemistry Research

Volumn 22, Issue 7, 2013, Pages 3452-3458

  Maity, Arindam ^a   Hazra, Abhijit ^a   Palit, Partha ^a,c   Mondal, Shymal ^a   Lala, Sanchaita ^b   Mondal, Nirup B ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

^b Department of Zoology ^*  (India)

^c Dr B C Roy College of Pharmacy and Allied Health Sciences   (India)

Author keywords

Diketopiperazines; In vitro; In vivo studies; Leishmania donovani

Indexed keywords

1,4 BIS (2 CHLOROPHENYL)PIPERAZINE 2,5 DIONE; 1,4 BIS (CHLOROPHENYL)PIPERAZINE 2,5 DIONE; 1,4 DICYLOHEXYLPIPERAZINE 2,5 DIONE; ANTILEISHMANIAL AGENT; ENZYME; PIPERAZINEDIONE; UNCLASSIFIED DRUG; UREA;

AMASTIGOTE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG CYTOTOXICITY; ENZYME BLOOD LEVEL; IN VITRO STUDY; IN VIVO STUDY; KIDNEY FUNCTION; LEISHMANIA DONOVANI; LIVER FUNCTION; MOUSE; NONHUMAN; PARASITE LOAD; PERITONEUM MACROPHAGE; PROMASTIGOTE; STRUCTURE ACTIVITY RELATION; UREA BLOOD LEVEL; VISCERAL LEISHMANIASIS;

EID: 84878839704     PISSN: 10542523     EISSN: 15548120     Source Type: Journal    
DOI: 10.1007/s00044-012-0355-9     Document Type: Article

References (35)

1. Berman JD (1997) Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years. Clin Infect Dis 24:684-703
2. Chai CLL, Hockless DCR, Weerasauria KDV (1997) Synthesis and characterization of the first gold (I) complex of reduced epidithiopiperazine-2, 5-dione. Polyhedron 16:1577-1580
3. Chakrabarti G, Basu A, Manna PP, Mahato SB, Mandal NB, Bandyoapadhyay S (1999) Indolylquinoline derivatives are cytotoxic to Leishmania donovani promastigotes and amastigotes in vitro and are effective in treating murine visceral leishmaniasis. J Antimicrob Chemother 43:359-366
4. Chan-Bacab MJ, Penia-Rodriguez LM (2001) Plant natural products with leishmanicidal activity. Nat Prod Rep 18:674-688
5. Dey T, Anam K, Afrin F, Ali N (2000) Antileishmanial activities of stearylamine-bearing liposomes. Antimicrob Agents Chemother 44:1739-1742
6. Dinsmore CJ, Beshore DC (2002) Recent advances in the synthesis of diketopiperazines. Tetrahedron 58:3297-3312
7. Doemling A (2005) Organic Chemistry highlights. http://www. organicchemistryhighlights.org//2005/05July.shtm. Accessed 5 July 2005
8. Ghosh AK, Rakshit MM, Ghosh DK (1983) Effect of berberine chloride on Leishmania donovani. Indian J Med Res 78:407-416
9. Hazra A, Paira P, Palit P, Banerjee S, Mondal NB, Sahu NP (2007) Synthesis of symmetrically 1,4-disubstituted piperazine-2,5-diones: a new class of antileishmanial agents. J Chem Res 381-83
10. Ikeda Y, Matsuki T, Ogawa T, Munaka T (1983) Safracins, new antitumor antibiotics. II. Physicochemical properties and chemical structures. J Antibiot 36:1284-1289
11. Jaffe CL, Grimaldi G, McMohan-Pratt D (1984) In: Morel CM (ed) Genes and antigens of parasites, a laboratory manual, 2nd edn. Fundacao Oswaldo Cruz, Rio de Janiero, p 47
12. Jha T, Sundar S, Thakur CP, Bachmann P, Karbwang J, Fischer C, Voss A, Berman J (1999) Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis. N Engl J Med 341:1795-1800
13. Lautru S, Gondry M, Genet R, Pernodet J (2002) The albonoursin gene cluster of S. noursei: biosynthesis of diketopiperazine metabolites independent of nonribosomal peptide synthetases. Chem Biol 9:1355-1364
14. Mayence A, Eynde VJJ, LeCour L Jr, Walker AL, Tekwani LB, Huang LT (2004) Piperazine-linked bisbenzamidines: a novel class of antileishmanial agents. Eur J Med Chem 39(6):547-553
15. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immuno Method 65:55-63
16. Nwaka S, Hudson A (2006) Innovative lead discovery strategies for tropical diseases. Nat Rev Drug Discov 5:941-955
17. O'Reilly E, Lestini E, Balducci D, Paradisi F (2009) One-step diketopiperazine synthesis using phase transfer catalysis. Tetrahedron Lett 50:1748-1750
18. O'Reilly E, Pes L, Paradisi F (2010) From amines to diketopiperazines: a one-pot approach. Tetrahedron Lett 51:1696-1697
19. Olliaro PL, Bryceson ADM (1993) Practical progress and new drugs for changing patterns of leishmaniasis. Parasitol Today 9:323-328
20. Pal C, Raha M, Basu A, Roy KC, Gupta A, Ghosh M, Sahu NP, Banerjee S, Mandal NB, Bandyopadhyay S (2002) Combination therapy with indolylquinoline derivative and sodium antimony gluconate cures established visceral leishmaniasis in hamsters. Antimicrob Agents Chemother 46:259-261
21. Palit P, Hazra A, Maity A, Vijayan RSK, Manoharan P, Banerjee S, Mondal NB, Ghoshal N, Ali N (2012) Discovery of safe and orally effective 4-aminoquinaldine analogues as apoptotic inducers with activity against experimental visceral leishmaniasis. Antimicrob Agents Chemother 56(1):432-445
22. Pecoul B (2004) New drugs for neglected diseases: from pipeline to patients. PLoS Med 1:e6
23. Peters W (1981) The treatment of kala-azar-new approaches to an old problem. Indian J Med Res 73(Suppl):1-18
24. Sahu NP, Pal C, Mandal NB, Banerjee S, Raha M, Kundu AP, Basu A, Ghosh M, Roy K, Bandyopadhyay S (2002) Synthesis of a novel quinoline derivative, 2-(2-methylquinolin-4-ylamino)-N-phenylacetamide - a potential antileishmanial agent. Bioorg Med Chem 10:1687-1693
25. Sahu NP, Mandal NB, Banerjee S, Kundu AP, Raha M, Bandyopadhay S, Pal C, Basu A, Chakrabarti G (2004) December 13. Indian Patent No. 191818
26. Savioli L et al (2006) Response from Savioli and colleagues from the Department of Neglected Tropical Diseases, World Health Organization. PLoS Med 3:e283
27. Stauber LA, Franchino EN, Grun J (1958) An eight-day method for screening compounds against Leishmania donovani in the Golden Hamster. J Protozool 5:269-273
28. Sundar S, Makharia A, More D, Agarwal G, Voss A, Fischer C, Bachmann P, Murray (2000) Short-course of oral miltefosine for treatment of visceral leishmaniasis. Clin Infect Dis 31:1110-1113
29. Vande Wa EA, Tracy JW (1993) Agentes antiparasitarios. In: Smith C, Reynard A (eds) Farmacología. Editorial Médica - Panamericana, Buenos Aires, pp 862-884
30. Wang Y, Gloer JB, Scott JA, Malloch D (1995) Terezines A-D: new amino acid-derived bioactive metabolites from the coprophilous fungus Sporormiella teretispora. J Nat Prod 58:93-99
31. Wolday D, Bevhe N, Akuffo H, Britton S (1999) Leishmania-HIV interaction: immunopathogenic Mechanisms. Parasitol Today 15:182-187
32. World Health Organisation (1998) Leishmenia and HIV in gridlock. UNAIDS, Geneva
33. World Health Organization (1999) Tropical disease research: progress in international research, 1997-1998. World Health Organization, Geneva
34. World Health Organization (2010). Leishmaniasis: burden of disease. World Health Organization, Geneva. http://www.who.int/leishmaniasis/burden/en
35. World Health Organization (WHO) (2002) Programme for the surveillance and control of leishmaniasis http://www.who.int/leishmaniasis/surveillance/en/